SCHEMBL4674685

SCHEMBL4674685

O=S(=O)(c1ccc(Cl)cc1)C1CC[N]CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.43
CYP3A4 P08684 1/20 0.43
MAPK1 P28482 1/20 0.43
HTR2A P28223 3/20 0.42
HTR2C P28335 2/20 0.42
DRD2 P14416 1/20 0.42
KCNH2 Q12809 1/20 0.42
CA1 P00915 3/20 0.41
CA2 P00918 3/20 0.41
CA12 O43570 2/20 0.41
CA3 P07451 2/20 0.41
CA4 P22748 2/20 0.41
CA6 P23280 2/20 0.41
CA5A P35218 2/20 0.41
CA7 P43166 2/20 0.41
CA9 Q16790 2/20 0.41
CA13 Q8N1Q1 2/20 0.41
CA14 Q9ULX7 2/20 0.41
CA5B Q9Y2D0 2/20 0.41
PSEN1 P49768 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL217625 0.82 ALDH1A1 (0.48) ALDH1A1CYP3A4MAPK1HTR2AHTR2C
SCHEMBL2303097 0.81 GAA (0.43) ALDH1A1CYP3A4HTR2AHTR2CCA1
SCHEMBL765653 0.81 ALDH1A1 (0.49) ALDH1A1CYP3A4MAPK1HTR2AHTR2C
SCHEMBL2100232 0.81 HTR2A (0.51) ALDH1A1HTR2AHTR2CDRD2KCNH2
SCHEMBL2798239 0.78 MAPT (0.50) ALDH1A1CYP3A4MAPK1HTR2AHTR2C
Hydrochloric Acid SCHEMBL5271819 0.76 MAPT (0.49) ALDH1A1CYP3A4MAPK1HTR2AHTR2C
SCHEMBL31713765 0.74 ALDH1A1 (0.46) ALDH1A1HTR2AHTR2CKCNH2MMP1
SCHEMBL15152636 0.74 MAPT (0.46) ALDH1A1CYP3A4MAPK1HTR2AHTR2C
SCHEMBL15152638 0.74 MAPT (0.46) ALDH1A1CYP3A4MAPK1HTR2AHTR2C
SCHEMBL21032959 0.71 ALDH1A1 (0.41) ALDH1A1CYP3A4MAPK1HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0958287-B2 SULFAMIDE-METALLOPROTEASE INHIBITORS HOFFMANN LA ROCHE (CH) 2008-04-09 EP disclosed
EP-0958287-B1 SULFAMIDE-METALLOPROTEASE INHIBITORS HOFFMANN LA ROCHE (CH) 2002-09-11 EP disclosed
US-6376506-B1 REACTING SULFAMOYL OXAZOLIDONE WITH (1,2,3,4)-TETRAHYDRO-BETA-CARBOLINE TO FORM INHIBITOR; USED TO TREAT ARTHRITIS, OSTEOPOROSIS, PERIODONTAL DISEASE, CARDIOVASCULAR DISEASES, MULTIPLE SCLEROSIS, AND TUMORS SYNTEX (U.S.A.) LLC 2002-04-23 US disclosed